Patients with chronic lumbago

Patients without chronic lumbago

P value

N

21

31

Age, years

73.1 ± 5.0

70.1 ± 8.3

0.21

Male, %

32

57

0.06

Duration from onset

6.7 ± 4.8

5.7 ± 4.1

0.36

BMI, kg/mm²

21.3 ± 3.5

21.1 ± 3.0

0.83

Waist hip ratio

0.85 ± 0.11

0.85 ± 0.08

0.70

College graduate (%)

66.7

74.2

0.39

High economic status (%)

19.0

29.0

0.57

Hoehn-Yhar stage

3.5 ± 0.8

2.7 ± 0.9

0.00

Medications

Levodopa (mg)

513 ± 175

364 ± 199

0.00

Pramipexoe (mg)

1.8 ± 1.2 (n = 6)

1.9 ± 0.9 (n = 17)

1.00

Ropinirole (mg)

10.4 ± 4.3 (n = 5)

10.0 ± 3.1 (n = 6)

0.46

Selegiline (%)

28.6

32.3

0.78

Entacapone (%)

19.0

6.5

0.28

Amantagine (%)

47.6

35.5

0.35

Zonisamide (%)

14.3

6.5

0.25

Trihexyphenidile (%)

27.8

4.8

0.02

Donepezil (%)

19.0

6.5

0.16

BMI: body mass index